Upexi (UPXI) Stock Price, News & Analysis

Company Overview

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

Key Stats

• Today's Range: $2.83 to $3.47
• 50-Day Range: $2.60 to $15.51
• 52-Week Range: $1.90 to $22.57
• Volume: 6.56 million shs
• Average Volume: 1.04 million shs
• Market Capitalization: $123.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.00
• Consensus Rating: Buy

Upexi Stock Analysis - MarketRank™

Upexi scored higher than 69% of companies evaluated by MarketBeat, and ranked 319th out of 906 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Upexi has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Upexi has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Upexi has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.63% of the float of Upexi has been sold short.

Short Interest Ratio / Days to Cover

Upexi has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Upexi has recently increased by 63.11%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Upexi does not currently pay a dividend.

Dividend Growth

Upexi does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.63% of the float of Upexi has been sold short.

Short Interest Ratio / Days to Cover

Upexi has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Upexi has recently increased by 63.11%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.73

News Sentiment

Upexi has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Upexi this week, compared to 1 article on an average week.

Search Interest

Only 3 people have searched for UPXI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

13 people have added Upexi to their MarketBeat watchlist in the last 30 days. This is an increase of 550% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Upexi insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,150,004.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

31.60% of the stock of Upexi is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 5.68% of the stock of Upexi is held by institutions.

UPXI Stock Analysis - Frequently Asked Questions

How have UPXI shares performed this year?

Upexi's stock was trading at $3.51 at the beginning of 2025. Since then, UPXI shares have decreased by 7.0% and is now trading at $3.2650.

How were Upexi's earnings last quarter?

Upexi, Inc. (NASDAQ:UPXI) posted its quarterly earnings data on Friday, May, 16th. The company reported ($2.87) earnings per share (EPS) for the quarter. The firm had revenue of $3.16 million for the quarter. Upexi had a negative net margin of 135.86% and a negative trailing twelve-month return on equity of 535.19%.

When did Upexi's stock split?

Upexi shares reverse split on Thursday, October 3rd 2024.The 1-20 reverse split was announced on Thursday, October 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Upexi?

Shares of UPXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Upexi own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Upexi investors own include Ford Motor (F), Meta Platforms (META), Tesla (TSLA), Walt Disney (DIS), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Devon Energy (DVN).

Company Calendar

• Last Earnings: 5/16/2025
• Today: 7/03/2025
• Next Earnings (Estimated): 7/08/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:UPXI
• CIK: 1775194
• Web: groveinc.io
• Phone: 701-353-5425
• Fax: N/A
• Employees: 130
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $16.00
• High Stock Price Target: $16.00
• Low Stock Price Target: $16.00
• Potential Upside/Downside: +385.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$23.66 million
• Net Margins: -135.86%
• Pretax Margin: -124.52%
• Return on Equity: -535.19%
• Return on Assets: -122.94%

Debt

• Debt-to-Equity Ratio: 0.31
• Current Ratio: 0.37
• Quick Ratio: 0.24

Sales & Book Value

• Annual Sales: $26 million
• Price / Sales: 4.81
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.24 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 37,920,000
• Free Float: 25,934,000
• Market Cap: $124.98 million
• Optionable: Optionable
• Beta: -0.58